Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 1.82M | $ 4.80M | $ 5.33M | $ 8.06M | $ 8.83M |
Total Assets | $ 16.51M | $ 17.39M | $ 16.48M | $ 17.52M | $ 17.15M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 1.64M | $ 1.86M | $ 1.52M | $ 1.54M | $ 1.29M |
Stockholders Equity | $ 14.87M | $ 15.53M | $ 14.96M | $ 15.98M | $ 15.85M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |